Desh Rakshak Aushdhalaya Ltd

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on October 14, 2024. The stock has been given a 'Hold' rating by MarketsMOJO and is currently trading higher than its moving averages. The company has shown a significant growth of 116.31% in the past year, outperforming the Sensex.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on October 8th, 2024. The stock is currently trading at Rs.12.39, outperforming the sector by 3.74%. With a 'Hold' rating from MarketsMOJO and consistent growth, it is a promising option for investors in the healthcare industry.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on October 4th, 2024. The stock is currently trading at Rs.11.8, outperforming the sector by 4.44%. This can be attributed to the company's strong financials and consistent growth. According to MarketsMOJO, the stock is currently rated as 'Hold', indicating promising growth but not recommended for immediate purchase or sale. The stock has shown erratic trading behavior in the past 20 days, but is currently trading higher than its moving averages. Desh Rakshak Aushdhalaya has outperformed the Sensex by a significant margin, showcasing its strong growth potential and ability to generate returns for investors.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on July 12, 2024. The stock has outperformed the sector by 5.28% and is currently trading higher than its moving averages. With a strong 1-year performance and a 'Hold' call from MarketsMOJO, the company shows potential for growth in the pharma industry.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on July 11, 2024. With a 'Hold' rating from MarketsMOJO, the stock has shown positive performance and is currently trading higher than its moving averages. It has also outperformed the Sensex, showcasing strong growth potential and positive market sentiment.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on June 27, 2024. The stock is currently trading at Rs.9.26, outperforming the sector by 5.66%. According to MarketsMOJO, the stock is rated as 'Hold', indicating positive performance but not a strong buy at the moment. The company has outperformed the Sensex, showcasing strong growth potential and positive market sentiment.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on June 24, 2024. It has outperformed the sector by 4.94% and has shown consistent gains in the last four days. The company's strong performance in the past year indicates its potential for growth in the market.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on June 21, 2024. The stock has been performing well, outperforming the sector by 4.65% and trading higher than its moving averages. It has also shown strong performance in the market, outperforming the Sensex by 39.77% in the last year. However, erratic trading behavior should be noted.

Desh Rakshak Aushdhalaya, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on June 20, 2024. The stock has outperformed the sector by 4.98% and has shown consecutive gains for the past 2 days. However, erratic trading behavior and lack of external data should be considered.